跳至主要内容
临床试验/EUCTR2010-023903-91-SK
EUCTR2010-023903-91-SK进行中(未招募)不适用

A randomized phase II dose-finding study of hexaminolevulinate (HAL) photodynamic therapy (PDT) in patients with low/moderate-grade cervical intraepithelial neoplasia (CIN1 or 2).

Photocure ASA0 个研究点目标入组 240 人开始时间: 2011年3月16日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Photocure ASA
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Patients with ectocervical CIN1 or CIN2 as verified by local pathology (biopsy) obtained within the last month
  • Satisfactory colposcopy examination including:
  • ovisibility of entire transformation zone including the squamocolumnar junction and
  • ovisibility of entire lesion margin
  • Negative endocervical os by colposcopy
  • Colposcopical visible lesion at visit 2, before treatment
  • Patients with an average sized uterine cervix (approximately 27mm diameter) suitable for application of the Klemcap
  • Age 18 or above
  • Written informed consent signed
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 200
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 40

排除标准

  • Previous treatment of CIN or invasive disease
  • Lesion(s) extending to the vaginal vault
  • Atypical glandular cells (AGC) or adenocarcinoma in situ (AIS) on cytology, malignant cells on cytology or histology or other suspicion of either micro-invasive or invasive disease
  • Suspicion of endocervical disease on colposcopy
  • Current severe pelvic inflammatory disease, severe cervicitis, or other severe gynaecological infection as per colposcopy and clinical examination
  • Undiagnosed vaginal bleeding
  • History of toxic shock syndrome
  • Known or suspected porphyria
  • Known allergy to hexaminolevulinate or similar compounds (e.g. methyl aminolevulinate or aminolevulinic acid)
  • Pregnancy, or intention to become pregnant during the study period
  • Childbirth or miscarriage within six weeks of enrolment
  • Use of heart pacemaker
  • Participation in other clinical studies either concurrently or within the last 30 days
  • Risk of poor protocol compliance. Patient participation should be considered with respect to living far away from the hospital, plans for moving to another city/state, frequent travelling, planning to become pregnant, drug abuse/alcoholic, difficult working hours, family obligations, other illness (e.g. psychiatric), etc.
  • Unwillingness to use adequate birth control (not abstinence) from screening until last PDT
  • Patient is the investigator or any sub-investigator, research assistant, pharmacist, study coordinator, other staff or relative thereof directly involved in the conduct of the protocol

研究者

发起方
Photocure ASA

相似试验

进行中(未招募)
不适用
A dose finding study of hexaminolevulinate photodynamic therapy in patients with mild to moderate abnormal cell changes of the cervixPatients with low/moderate-grade cervical intraepithelial neoplasia (CIN1 or 2).MedDRA version: 14.1Level: LLTClassification code 10066238Term: Cervical low grade squamous intraepithelial lesionSystem Organ Class: 10038604 - Reproductive system and breast disorders
EUCTR2010-023903-91-DEPhotocure ASA240
进行中(未招募)
1 期
A dose finding study of hexaminolevulinate photodynamic therapy in patients with mild to moderate abnormal cell changes of the cervixPatients with low/moderate-grade cervical intraepithelial neoplasia (CIN1 or 2).MedDRA version: 14.0Level: LLTClassification code 10066238Term: Cervical low grade squamous intraepithelial lesionSystem Organ Class: 10038604 - Reproductive system and breast disorders
EUCTR2010-023903-91-CZPhotocure ASA240
进行中(未招募)
不适用
A randomized phase II dose-finding study of hexaminolevulinate (HAL) photodynamic therapy (PDT) in patients with low-grade cervical intraepithelial neoplasia.ow grade cervical intraepithelial neoplasia (CIN)MedDRA version: 9.1Level: LLTClassification code 10066238Term: Cervical low grade squamous intraepithelial lesion
EUCTR2008-004604-31-DEPhotocure ASA70
进行中(未招募)
1 期
A randomized phase II dose-finding study of hexaminolevulinate (HAL) photodynamic therapy (PDT) in patients with low-grade cervical intraepithelial neoplasia (CIN1).
EUCTR2008-004604-31-FRPhotocure ASA
进行中(未招募)
不适用
A Phase II Dose-Finding Study of weekly pemetrexed in combination with Radiotherapy in locally advanced pancreatic adenocarcinoma - ND
EUCTR2007-002936-27-ITISTITUTO ONCOLOGICO ROMAGNOLO